Cite
Hu M, Lei XY, Larson JD, et al. Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. Biomaterials. 2021;280:121276doi: 10.1016/j.biomaterials.2021.121276.
Hu, M., Lei, X. Y., Larson, J. D., McAlonis, M., Ford, K., McDonald, D., Mach, K., Rusert, J. M., Wechsler-Reya, R. J., & Mali, P. (2021). Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. Biomaterials, 280121276. https://doi.org/10.1016/j.biomaterials.2021.121276
Hu, Michael, et al. "Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures." Biomaterials vol. 280 (2021): 121276. doi: https://doi.org/10.1016/j.biomaterials.2021.121276
Hu M, Lei XY, Larson JD, McAlonis M, Ford K, McDonald D, Mach K, Rusert JM, Wechsler-Reya RJ, Mali P. Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. Biomaterials. 2021 Dec 02;280:121276. doi: 10.1016/j.biomaterials.2021.121276. Epub 2021 Dec 02. PMID: 34890975.
Copy
Download .nbib